Neurogenetics,
Journal Year:
2024,
Volume and Issue:
25(2), P. 103 - 117
Published: Feb. 21, 2024
Abstract
Epilepsy
is
a
complex
genetic
disorder
that
affects
about
2%
of
the
global
population.
Although
frequency
and
severity
epileptic
seizures
can
be
reduced
by
range
pharmacological
interventions,
there
are
no
disease-modifying
treatments
for
epilepsy.
The
development
new
more
effective
drugs
hindered
lack
suitable
animal
models.
Available
rodent
models
may
not
recapitulate
all
key
aspects
disease.
Spontaneous
convulsions
were
observed
in
few
Göttingen
Minipigs
(GMPs),
which
provide
valuable
alternative
model
characterisation
epilepsy-type
diseases
testing
treatments.
We
have
characterised
affected
GMPs
at
genome
level
taken
advantage
primary
fibroblast
cultures
to
validate
functional
impact
fixed
variants
on
transcriptome
level.
found
numerous
genes
connected
calcium
metabolism
been
associated
with
epilepsy
before,
such
as
ADORA2B
,
CAMK1D
ITPKB
MCOLN2
MYLK
NFATC3
PDGFD
PHKB
.
Our
results
identified
two
transcription
factor
genes,
EGR3
HOXB6
potential
regulators
CACNA1H
was
previously
linked
disorders
humans.
findings
first
set
conclusive
support
use
subsets
an
reliable
system
study
human
Further
neurological
validation
suitability
therefore
warranted.
JAMA Psychiatry,
Journal Year:
2024,
Volume and Issue:
81(9), P. 870 - 870
Published: May 22, 2024
Importance
The
risk
of
mental
disorders
is
consistently
associated
with
variants
in
CACNA1C
(L-type
calcium
channel
Cav1.2)
but
it
not
known
why
these
channels
are
critical
to
cognition,
and
whether
they
affect
the
layer
III
pyramidal
cells
dorsolateral
prefrontal
cortex
that
especially
vulnerable
cognitive
disorders.
Objective
To
examine
molecular
mechanisms
expressed
primate
cortices.
Design,
Setting,
Participants
design
included
transcriptomic
analyses
from
human
macaque
cortex,
connectivity,
protein
expression,
physiology,
behavior
macaques.
research
was
performed
academic
laboratories
at
Yale,
Harvard,
Princeton,
University
Pittsburgh.
As
only
exists
primates,
work
evaluated
humans
Main
Outcomes
Measures
Outcome
measures
signatures
cells,
expression
interactions
using
light
electron
microscopy,
changes
neuronal
firing
during
spatial
working
memory,
memory
performance
following
pharmacological
treatments.
Results
Layer
coexpress
a
constellation
calcium-related
proteins,
delineated
by
CALB1
(calbindin),
high
levels
(Cav1.2),
GRIN2B
(NMDA
receptor
GluN2B),
KCNN3
(SK3
potassium
channel),
concentrated
dendritic
spines
near
calcium-storing
smooth
endoplasmic
reticulum.
L-type
influenced
needed
for
where
either
blockade
or
increased
drive
β1-adrenoceptors,
reduced
mean
(SD)
37.3%
(5.5%)
40%
(6.3%),
respectively,
latter
via
SK
opening.
An
blocker
β1-adrenoceptor
antagonist
protected
stress.
Conclusions
Relevance
differentially
express
calbindin
proteins
including
Cav1.2
(
),
GluN2B-NMDA
receptors
SK3
which
influence
memory-related
firing.
finding
inadequate
excessive
activation
explains
loss-
gain-of-function
were
selective
highlights
importance
regulatory
neurons
signaling,
consistent
Alzheimer
tau
pathology
emerging
when
lost
age
and/or
inflammation.
PLoS ONE,
Journal Year:
2025,
Volume and Issue:
20(1), P. e0315230 - e0315230
Published: Jan. 24, 2025
Legg-Calvé-Perthes
disease
(LCPD)
involves
femoral
head
osteonecrosis
caused
by
disrupted
blood
supply,
leading
to
joint
deformity
and
early
osteoarthritis.
This
study
investigates
the
role
of
miRNA-223-5p
in
regulating
hypoxia-induced
apoptosis
enhancing
osteogenesis
bone
marrow
mesenchymal
stem
cells
(BMSCs).
Utilizing
a
juvenile
New
Zealand
white
rabbit
model
LCPD
established
through
neck
ligation,
we
transfected
BMSCs
with
miR-223-5p
mimics,
inhibitors,
controls,
followed
hypoxic
exposure.
The
impact
on
BMSC
was
assessed
using
qPCR,
Western
blotting,
dual-luciferase
reporter
assays,
focusing
Wnt/β-catenin
signaling
pathway.
In
vivo,
evaluated
effects
transplanting
miR-223-5p-overexpressing
into
model.
Our
results
indicate
that
is
downregulated
under
conditions.
Overexpression
inhibited
activated
pathway
directly
targeting
CHAC2.
enhanced
reduced
necrosis
These
findings
suggest
inhibits
CHAC2
activating
pathway,
proposing
as
promising
target
for
improving
repair
ischemic
Molecular Psychiatry,
Journal Year:
2024,
Volume and Issue:
29(10), P. 3195 - 3207
Published: May 4, 2024
Sensory
abnormalities
are
observed
in
~90%
of
individuals
with
autism
spectrum
disorders
(ASD),
but
the
underlying
mechanisms
poorly
understood.
GluN2B,
an
NMDA
receptor
subunit
that
regulates
long-term
depression
and
circuit
refinement
during
brain
development,
has
been
strongly
implicated
ASD,
whether
GRIN2B
mutations
lead
to
sensory
remains
unclear.
Here,
we
report
Grin2b-mutant
mice
show
behavioral
hypersensitivity
hyperconnectivity
associated
anterior
cingulate
cortex
(ACC).
a
patient-derived
C456Y
mutation
(Grin2b
Physiological Research,
Journal Year:
2024,
Volume and Issue:
Suppl 1, P. S413 - S434
Published: Aug. 22, 2024
N-methyl-D-aspartate
receptors
(NMDARs)
are
a
subtype
of
ionotropic
glutamate
critical
for
synaptic
transmission
and
plasticity,
the
development
neural
circuits.
Rare
or
de-novo
variants
in
GRIN
genes
encoding
NMDAR
subunits
have
been
associated
with
neurodevelopmental
disorders
characterized
by
intellectual
disability,
developmental
delay,
autism,
schizophrenia,
epilepsy.
In
recent
years,
some
disease-associated
using
recombinant
expressed
non-neuronal
cells,
few
also
studied
neuronal
preparations
animal
models.
Here
we
review
current
literature
on
functional
evaluation
human
GRIN1,
GRIN2A
GRIN2B
at
all
levels
analysis.
Focusing
impact
different
patient
level
receptor
function,
discuss
effects
agonist
co-agonist
affinity,
channel
open
probability,
cell
surface
expression.
We
consider
how
such
receptor-level
information
may
be
used
to
classify
as
gain-of-function
loss-of-function,
limitations
this
classification
synaptic,
cellular,
system
level.
Together
work
many
laboratories
worldwide
yields
valuable
insights
into
structure
represents
significant
progress
effort
understand
treat
disorders.
Keywords:
NMDA
,
genes,
Genetic
variants,
Electrophysiology,
Synapse,
Animal
Cerebral Cortex,
Journal Year:
2024,
Volume and Issue:
34(13), P. 161 - 171
Published: May 1, 2024
Autism
spectrum
disorder
(ASD)
is
a
developmental
with
rising
prevalence
and
unknown
etiology
presenting
deficits
in
cognition
abnormal
behavior.
We
hypothesized
that
the
investigation
of
synaptic
component
prefrontal
cortex
may
provide
proteomic
signatures
identify
biological
underpinnings
cognitive
childhood
ASD.
Subcellular
fractions
synaptosomes
from
cortices
age-,
brain
area-,
postmortem-interval-matched
samples
children
adults
idiopathic
ASD
vs.
controls
were
subjected
to
HPLC-tandem
mass
spectrometry.
Analysis
data
revealed
enrichment
risk
genes
participate
slow
maturation
postsynaptic
density
(PSD)
structure
function
during
early
development.
Proteomic
analysis
down
regulation
PSD-related
proteins
including
AMPA
NMDA
receptors,
GRM3,
DLG4,
olfactomedins,
Shank1-3,
Homer1,
CaMK2α,
NRXN1,
NLGN2,
Drebrin1,
ARHGAP32,
Dock9
autism
(FDR-adjusted
P
<
0.05).
In
contrast,
alterations
less
severe
or
unchanged
adult
individuals
Network
analyses
glutamate
receptor
abnormalities.
Overall,
support
concept
synaptopathy
involving
genes.
Interruption
evolutionarily
conserved
PSD
complex
lead
development
susceptible
individual.
Alzheimer s Research & Therapy,
Journal Year:
2025,
Volume and Issue:
17(1)
Published: Jan. 4, 2025
Abstract
Background
PSEN1,
PSEN2,
and
APP
mutations
cause
Alzheimer’s
disease
(AD)
with
an
early
age
at
onset
(AAO)
progressive
cognitive
decline.
PSEN1
are
more
common
generally
have
earlier
AAO;
however,
certain
a
later
AAO,
similar
to
those
observed
in
PSEN2
.
Methods
We
examined
whether
endotypes
exist
across
these
AAO
(~
55
years)
using
hiPSC-derived
neurons
from
familial
(FAD)
patients
harboring
A79V
,
N141I
V717I
mechanistically
characterized
by
integrating
RNA-seq
ATAC-seq.
Results
identified
endotypes,
such
as
dedifferentiation,
dysregulation
of
synaptic
signaling,
repression
mitochondrial
function
metabolism,
inflammation.
ascertained
the
master
transcriptional
regulators
associated
including
REST,
ASCL1,
ZIC
family
members
(activation),
NRF1
(repression).
Conclusions
FAD
share
regulatory
changes
within
varying
severity,
resulting
reversion
less-differentiated
state.
The
mechanisms
described
offer
potential
targets
for
therapeutic
interventions.
ABSTRACT
Background
SYNGAP1
encodes
a
Ras/Rap
GTPase‐activating
protein
that
is
predominantly
expressed
in
the
brain
with
functional
roles
regulating
synaptic
plasticity,
spine
morphogenesis,
and
cognition
function.
Pathogenic
variants
have
been
associated
spectrum
of
neurodevelopmental
disorders
characterized
by
developmental
delays,
intellectual
disabilities,
epilepsy,
hypotonia,
features
autism
disorder.
The
aim
this
study
was
to
identify
novel
gene
variant
linked
evaluate
pathogenicity
detected
variant.
Methods
A
de
novo
intronic
identified
Whole
exome
sequencing
(WES)
confirmed
Sanger
sequencing.
Minigene
assays
were
conducted
assess
whether
influenced
normal
splicing
mRNA.
Results
(c.3582+2T>G)
indentified
clinical
suggestive
related
disorders.
analysis
demonstrated
noncanonical
splice
site
led
activation
cryptic
acceptor
site.
Consequently,
101
base
pairs
intron
16
aberrantly
retained
mRNA,
leading
frameshift.
This
frameshift
resulted
introduction
premature
stop
codon
(TGA)
coding
sequence
production
truncated
protein,
potentially
leding
loss
function
subsequent
disruption
its
biological
roles.
Conclusion
Our
findings
highlight
significance
pathogenic
at
16/exon
17
junction
‐related
disorders,
providing
insights
into
genetic
basis
diagnosis
these
disabilities.